Yes, there are ongoing clinical trials investigating TLR4-targeted therapies. Some trials are exploring the use of TLR4 antagonists to reduce inflammation and tumor growth, while others are evaluating TLR4 agonists to enhance the immune response against cancer. The outcomes of these trials will provide valuable insights into the feasibility and efficacy of TLR4-targeted treatments.
